Carlo Pozzilli | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Case Report: Multiple Sclerosis Relapses After Vaccination Against SARS-CoV2: A Series of Clinical Cases	FRONTIERS IN NEUROLOGY	2021
Dalfampridine improves slowed processing speed in multiple sclerosis patients with mild motor disability: post hoc analysis of a randomized controlled trial	THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS	2021
Ponesimod to treat multiple sclerosis	DRUGS OF TODAY	2021
Multi-scale resting state functional reorganization in response to multiple sclerosis damage	NEURORADIOLOGY	2020
Minimal evidence of disease activity (MEDA) in relapsing-remitting multiple sclerosis	JOURNAL OF NEUROLOGY, NEUROSURGERY AND PSYCHIATRY	2020
Resting-state functional connectivity of anterior and posterior cerebellar lobes is altered in multiple sclerosis	MULTIPLE SCLEROSIS	2020
Cesarean section in women with MS: A choice or a need?	MULTIPLE SCLEROSIS AND RELATED DISORDERS	2020
Dalfampridine to Improve Balance in Multiple Sclerosis: Substudy from a Randomized Placebo-Controlled Trial	NEUROTHERAPEUTICS	2020
Multiple sclerosis treatment and melanoma development	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES	2020
A Comprehensive Approach to Disentangle the Effect of Cerebellar Damage on Physical Disability in Multiple Sclerosis	FRONTIERS IN NEUROLOGY	2020
Transition to secondary progression in relapsing-onset multiple sclerosis: Definitions and risk factors	MULTIPLE SCLEROSIS	2020
Safety and efficacy of MD1003 (high-dose biotin) in patients with progressive multiple sclerosis (SPI2): a randomised, double-blind, placebo-controlled, phase 3 trial	LANCET NEUROLOGY	2020
Disease-modifying drugs can reduce disability progression in relapsing multiple sclerosis	BRAIN	2020
Ofatumumab versus Teriflunomide in Multiple Sclerosis	NEW ENGLAND JOURNAL OF MEDICINE	2020
Efficacy and Safety of Alemtuzumab Through 9 Years of Follow-up in Patients with Highly Active Disease: Post Hoc Analysis of CARE-MS I and II Patients in the TOPAZ Extension Study	CNS DRUGS	2020
The introduction of new medications in pediatric multiple sclerosis: Open issues and challenges	MULTIPLE SCLEROSIS	2020
Effectiveness of fingolimod in real-world relapsing-remitting multiple sclerosis Italian patients: the GENIUS study	NEUROLOGICAL SCIENCES	2020
Efficacy of alemtuzumab over 6 years in relapsing–remitting multiple sclerosis patients who relapsed between courses 1 and 2: Post hoc analysis of the CARE-MS studies	MULTIPLE SCLEROSIS	2020
Cost-Effectiveness Analysis of Cannabinoid Oromucosal Spray Use for the Management of Spasticity in Subjects with Multiple Sclerosis	CLINICAL DRUG INVESTIGATION	2020
Italian consensus on treatment of spasticity in multiple sclerosis	EUROPEAN JOURNAL OF NEUROLOGY	2020